share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  06/07 17:28
Moomoo AI 已提取核心訊息
SeaStar Medical Holding Corporation, a medical device company, has announced the completion of a 25-for-1 reverse stock split, effective as of 5:00 p.m. EDT on June 7, 2024. The reverse stock split was previously approved by the company's stockholders during a Special Meeting on September 6, 2023. Trading on a split-adjusted basis will commence on the Nasdaq Capital Market under the existing ticker symbol 'ICU' starting June 10, 2024. The reverse split aims to increase the market price of SeaStar Medical's common stock to meet Nasdaq's minimum bid price requirement. Post-split, the company will have approximately 3.1 million shares of common stock issued and outstanding. The company's transfer agent, Colonial Stock Transfer Company, Inc., will act as the exchange agent for...Show More
SeaStar Medical Holding Corporation, a medical device company, has announced the completion of a 25-for-1 reverse stock split, effective as of 5:00 p.m. EDT on June 7, 2024. The reverse stock split was previously approved by the company's stockholders during a Special Meeting on September 6, 2023. Trading on a split-adjusted basis will commence on the Nasdaq Capital Market under the existing ticker symbol 'ICU' starting June 10, 2024. The reverse split aims to increase the market price of SeaStar Medical's common stock to meet Nasdaq's minimum bid price requirement. Post-split, the company will have approximately 3.1 million shares of common stock issued and outstanding. The company's transfer agent, Colonial Stock Transfer Company, Inc., will act as the exchange agent for the reverse stock split. Stockholders holding shares through banks, brokers, or nominees will see their holdings automatically adjusted to reflect the reverse stock split. Additionally, the company filed the Second Certificate of Amendment to its Certificate of Incorporation with the Delaware Department of State, which became effective on the same day as the reverse split.
醫療器械公司SeaStar Medical Holding Corporation宣佈完成1股拆成25股的股票轉倉，該交易於2024年6月7日美東時間下午5點生效。此次股票轉倉已於2023年9月6日的特別股東會議上獲得批准。股票在納斯達克資本市場上以現有的股票代碼‘ICU’進行拆分調整交易，將於2024年6月10日開始。此次股票拆分旨在增加SeaStar Medical普通股的市場價格，以滿足納斯達克的最低買盤價格要求。拆分後，公司已發行和流通的普通股約爲310萬股。公司的股票轉讓代理Colonial Stock Transfer Company, Inc.將擔任股票轉倉的交易所。通過銀行業、經紀人或代理人持有股票的股東們將自動調整其持有股份以反映股票的拆分。此外，公司向特拉華州政府證券局提交了其公司章程的第二項修訂證書，這項修訂於股票拆分當天生效。
醫療器械公司SeaStar Medical Holding Corporation宣佈完成1股拆成25股的股票轉倉，該交易於2024年6月7日美東時間下午5點生效。此次股票轉倉已於2023年9月6日的特別股東會議上獲得批准。股票在納斯達克資本市場上以現有的股票代碼‘ICU’進行拆分調整交易，將於2024年6月10日開始。此次股票拆分旨在增加SeaStar Medical普通股的市場價格，以滿足納斯達克的最低買盤價格要求。拆分後，公司已發行和流通的普通股約爲310萬股。公司的股票轉讓代理Colonial Stock Transfer Company, Inc.將擔任股票轉倉的交易所。通過銀行業、經紀人或代理人持有股票的股東們將自動調整其持有股份以反映股票的拆分。此外，公司向特拉華州政府證券局提交了其公司章程的第二項修訂證書，這項修訂於股票拆分當天生效。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息